FDA Advisors Endorse Truvada to Prevent HIV Infection–But Big Questions Remain
Mark Mascolini (natap.org) An FDA advisory panel left little doubt that Truvada, the once-daily pill combining tenofovir and emtricitabine, will get its license extended to cover pre-exposure prophylaxis (PrEP) of HIV infection in adults with a high risk of picking up HIV sexually. But the thorny deliberations leading to that endorsement in a marathon 12.5-hour …
FDA Advisors Endorse Truvada to Prevent HIV Infection–But Big Questions Remain Read More »